Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA upgrades recalled broccoli to highest level
FDA upgrades recalled broccoli to highest level over possible Listeria contamination
The U.S. Food and Drug Administration upgraded the classification of recalled broccoli sold at Walmart originally issued in December to its highest recall category, according to the agency’s updated report.
Broccoli recall: FDA upgrades recall to ‘deadliest level’ for florets sold at Walmart in 20 states, throw out ASAP
The recall announced in January involves contaminated broccoli sold in 20 states. Here's everything you need to know
Walmart broccoli sold in Texas labeled as deadly. See list of FDA recalls so far in 2025
Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued by the agency.
Acrivon Therapeutics, FDA and Breakthrough Device
Acrivon Therapeutics:FDA Grants Breakthrough Device Designation For ACR-368 OncoSignature Assay
Wednesday, announced that the FDA has granted Breakthrough Device designation for the ACR-368 OncoSignature assay for the treatment of endometrial cancer. The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing,
Acrivon Therapeutics Gets FDA Breakthrough Device Designation for Cancer Identification
Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of endometrial cancer patients who may benefit from ACR-368 treatment.
ACR-368 OncoSignature assay gains FDA breakthrough status
Acrivon Therapeutics, Inc. (NASDAQ: ACRV), a clinical stage biopharmaceutical company with a market capitalization of $184 million and an impressive 60% stock return over the past year, announced that its ACR-368 OncoSignature assay has received Breakthrough Device designation from the U.
4h
on MSN
FDA Assigns Highest Risk Level To These Recalled Chocolate Snacks
The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...
1d
FDA is recalling more than 32,000 packages of these popular breadcrumbs sold nationwide
The California-based company has recalled 26,400 eight-ounce packages of its Unseasoned Bread Crumbs (Pan Rayado) and 6,240 ...
1d
on MSN
FDA approves pig organ transplant trials for patients with kidney failure
The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...
Cure Today
8h
FDA-Approved Calquence Combo Is First and Only of Its Kind in MCL
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
Interesting Engineering on MSN
18h
US FDA approves first-ever smart glasses with hearing aid for mild to moderate loss
EssilorLuxottica's Nuance Audio Glasses receive FDA clearance for OTC sales in the US, revolutionizing hearing solutions with ...
2d
What FDA Recalls In 2024 Taught Us About Food And Consumer Trust
From mislabeled allergens to major contamination scares, each incident was a reminder of how deeply food safety is woven into ...
healthday
5h
FDA Approves Susvimo for Diabetic Macular Edema
Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...
Targeted Oncology
10h
FDA Expands PATHWAY HER2 (4B5) Test to Include HER2-Ultralow Status
The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
Walmart
Chesapeake
Feedback